Jack Lief

2012

In 2012, Jack Lief earned a total compensation of $4M as President, Chief Executive Officer and Director at Arena Pharmaceuticals, a 218% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$569,250
Option Awards$2,116,650
Salary$690,000
Stock Awards$532,200
Other$81,485
Total$3,989,585

Lief received $2.1M in option awards, accounting for 53% of the total pay in 2012.

Lief also received $569.3K in non-equity incentive plan, $690K in salary, $532.2K in stock awards and $81.5K in other compensation.

Rankings

In 2012, Jack Lief's compensation ranked 1,649th out of 11,487 executives tracked by ExecPay. In other words, Lief earned more than 85.6% of executives.

ClassificationRankingPercentile
All
1,649
out of 11,487
86th
Division
Manufacturing
588
out of 4,253
86th
Major group
Chemicals And Allied Products
131
out of 1,198
89th
Industry group
Drugs
70
out of 920
92nd
Industry
Pharmaceutical Preparations
59
out of 700
92nd
Source: SEC filing on April 29, 2015.

Lief's colleagues

We found four more compensation records of executives who worked with Jack Lief at Arena Pharmaceuticals in 2012.

2012

Steven Spector

Arena Pharmaceuticals

General Counsel

2012

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2012

Robert Hoffman

Arena Pharmaceuticals

Chief Financial Officer

2012

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

In-depth

You may also like